Based on the mRNA sequencing data, FNRMS cases were accompanied by increased syndecan-4 mRNA expression (Fig. 8c) compared to that in FPRMS cases, suggesting syndecan-4 as a potential tumor driver gene in FNRMS promoting tumorigenesis. This evidence concerns the gene SDC4 and neoplasm.